Monoclonal Gammopathy of Undetermined Significance

"Monoclonal Gammopathy of Undetermined Significance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Conditions characterized by the presence of M protein (Monoclonal protein) in serum or urine without clinical manifestations of plasma cell dyscrasia.

Descriptor ID	D008998
MeSH Number(s)	C15.378.147.542.640 C15.378.147.780.570 C20.683.460.640 C20.683.780.640
Concept/Terms	Monoclonal Gammopathy of Undetermined Significance Monoclonal Gammopathy of Undetermined Significance Monoclonal Gammopathies, Benign Monoclonal Gammapathy of Undetermined Significance Benign Monoclonal Gammopathies Benign Monoclonal Gammopathy Monoclonal Gammopathy, Benign Monoclonal Gammapathies, Benign Benign Monoclonal Gammapathies Benign Monoclonal Gammapathy Monoclonal Gammapathy, Benign

Below are MeSH descriptors whose meaning is more general than "Monoclonal Gammopathy of Undetermined Significance".

Diseases [C]
Hemic and Lymphatic Diseases [C15]
Hematologic Diseases [C15.378]
Blood Protein Disorders [C15.378.147]
Hypergammaglobulinemia [C15.378.147.542]
Monoclonal Gammopathy of Undetermined Significance [C15.378.147.542.640]
Paraproteinemias [C15.378.147.780]
Monoclonal Gammopathy of Undetermined Significance [C15.378.147.780.570]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Hypergammaglobulinemia [C20.683.460]
Monoclonal Gammopathy of Undetermined Significance [C20.683.460.640]
Paraproteinemias [C20.683.780]
Monoclonal Gammopathy of Undetermined Significance [C20.683.780.640]

Below are MeSH descriptors whose meaning is related to "Monoclonal Gammopathy of Undetermined Significance".

Below are MeSH descriptors whose meaning is more specific than "Monoclonal Gammopathy of Undetermined Significance".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Monoclonal Gammopathy of Undetermined Significance" by people in this website by year, and whether "Monoclonal Gammopathy of Undetermined Significance" was a major or minor topic of these publications.

Bar chart showing 13 publications over 10 distinct years, with a maximum of 2 publications in 2022 and 2023 and 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2010	1	0	1
2013	1	0	1
2014	1	0	1
2016	0	1	1
2019	1	0	1
2020	0	1	1
2021	1	0	1
2022	2	0	2
2023	2	0	2
2024	1	1	2

Below are the most recent publications written about "Monoclonal Gammopathy of Undetermined Significance" by people in Profiles.

Hasanali ZS, Garfall AL, Burzenski L, Shultz LD, Tang Y, Kadu S, Sheppard NC, Liu W, Dopkin D, Vogl DT, Cohen AD, Waxman AJ, Susanibar-Adaniya SP, Carroll M, Stadtmauer EA, Allman D. Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient mice. JCI Insight. 2024 May 07; 9(10).

View in: PubMed
Joseph JM, Hillengass J, Tang L, Lesokhin AM, Landgren O, Usmani SZ, Moysich KB, McCann SE, Shah UA. Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population. Blood Adv. 2024 02 13; 8(3):538-548.

View in: PubMed
Epstein MM, Zhou Y, Castaneda-Avila MA, Cohen HJ. Multimorbidity in patients with monoclonal gammopathy of undetermined significance. Int J Cancer. 2023 06 15; 152(12):2485-2492.

View in: PubMed
Casta?eda-Avila MA, Mazor KM, Lapane KL, Epstein MM. Patient and provider-level drivers of healthcare utilization related to a diagnosis of a precancerous condition: monoclonal gammopathy of undetermined significance (MGUS). Cancer Causes Control. 2023 May; 34(5):449-457.

View in: PubMed
Casta?eda-Avila MA, Lapane KL, Person SD, Zhou Y, Gurwitz J, Mazor KM, Epstein MM. Multi-trajectory models of serum biomarkers among patients with monoclonal gammopathy of undetermined significance. Hematol Oncol. 2022 Aug; 40(3):409-416.

View in: PubMed
Casta?eda-Avila MA, Lapane KL, Person SD, Jesdale BM, Zhou Y, Mazor KM, Epstein MM. Differences in Hospital, Emergency Room and Outpatient Visits Among Adults With and Without Monoclonal Gammopathy of Undetermined Significance. Cancer Control. 2022 Jan-Dec; 29:10732748221126936.

View in: PubMed
Castaneda-Avila MA, Ulbricht CM, Epstein MM. Risk factors for monoclonal gammopathy of undetermined significance: a systematic review. Ann Hematol. 2021 Apr; 100(4):855-863.

View in: PubMed
Dong G, Mao L, Huang B, Gamalo-Siebers M, Wang J, Yu G, Hoaglin DC. The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring. J Biopharm Stat. 2020 09 02; 30(5):882-899.

View in: PubMed
Epstein MM, Saphirak C, Zhou Y, LeBlanc C, Rosmarin AG, Ash A, Singh S, Fisher K, Birmann BM, Gurwitz JH. Identifying monoclonal gammopathy of undetermined significance in electronic health data. Pharmacoepidemiol Drug Saf. 2020 01; 29(1):69-76.

View in: PubMed
Bhutani M, Turkbey B, Tan E, Korde N, Kwok M, Manasanch EE, Tageja N, Mailankody S, Roschewski M, Mulquin M, Carpenter A, Lamping E, Minter AR, Weiss BM, Mena E, Lindenberg L, Calvo KR, Maric I, Usmani SZ, Choyke PL, Kurdziel K, Landgren O. Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging. Leuk Lymphoma. 2016 May; 57(5):1114-21.

View in: PubMed

People

Explore

Similar Concepts

Top Journals